These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 9824602)

  • 21. [Do proton pump inhibitors after endoscopic control of acute ulcer hemorrhage have an advantage over H2 receptor antagonists?].
    Prassler R; Hendrich H; Barnert J; Richter G; Fleischmann R; Wienbeck M
    Z Gastroenterol; 1995 Aug; 33(8):431-4. PubMed ID: 7483734
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Heartburn-dominant, uninvestigated dyspepsia: a comparison of 'PPI-start' and 'H2-RA-start' management strategies in primary care--the CADET-HR Study.
    Armstrong D; Veldhuyzen van Zanten SJ; Barkun AN; Chiba N; Thomson AB; Smyth S; Sinclair P; Chakraborty B; White RJ;
    Aliment Pharmacol Ther; 2005 May; 21(10):1189-202. PubMed ID: 15882239
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Omeprazole 10 milligrams once daily, omeprazole 20 milligrams once daily, or ranitidine 150 milligrams twice daily, evaluated as initial therapy for the relief of symptoms of gastro-oesophageal reflux disease in general practice.
    Venables TL; Newland RD; Patel AC; Hole J; Wilcock C; Turbitt ML
    Scand J Gastroenterol; 1997 Oct; 32(10):965-73. PubMed ID: 9361167
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gastric acid secretion and plasma gastrin during short-term treatment with omeprazole and ranitidine in duodenal ulcer patients.
    Lazzaroni M; Sangaletti O; Bianchi Porro G
    Hepatogastroenterology; 1992 Aug; 39(4):366-70. PubMed ID: 1427586
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A comparison of intravenous ranitidine and omeprazole on gastric volume and pH in women undergoing emergency caesarean section.
    Tripathi A; Somwanshi M; Singh B; Bajaj P
    Can J Anaesth; 1995 Sep; 42(9):797-800. PubMed ID: 7497561
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical superiority of pantoprazole over ranitidine in the treatment of reflux esophagitis grade II and III. A prospective, double-blind, double-placebo study. Mexican clinical experience. Mexican Pantoprazole Study Group].
    Gallo S; Dibildox M; Moguel A; Di Silvio M; Rodríguez F; Almaguer I; García C
    Rev Gastroenterol Mex; 1998; 63(1):11-6. PubMed ID: 10068743
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acid suppression and upper GI bleeding.
    Netzer P; Inauen W
    Aliment Pharmacol Ther; 2000 Aug; 14(8):1104-5. PubMed ID: 10930909
    [No Abstract]   [Full Text] [Related]  

  • 28. Immediate acid-suppressing effects of ranitidine hydrochloride and rabeprazole sodium following initial administration and reintroduction: A randomized, cross-over study using wireless pH monitoring capsules.
    Ono S; Kato M; Ono Y; Imai A; Yoshida T; Shimizu Y; Asaka M
    J Gastroenterol Hepatol; 2009 Apr; 24(4):639-45. PubMed ID: 19032447
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of primed infusions with high dose ranitidine and omeprazole to maintain high intragastric pH in patients with peptic ulcer bleeding: a prospective randomised controlled study.
    Labenz J; Peitz U; Leusing C; Tillenburg B; Blum AL; Börsch G
    Gut; 1997 Jan; 40(1):36-41. PubMed ID: 9155573
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clonidine reduces diarrhea and sodium loss in patients with proximal jejunostomy: a controlled study.
    Buchman AL; Fryer J; Wallin A; Ahn CW; Polensky S; Zaremba K
    JPEN J Parenter Enteral Nutr; 2006; 30(6):487-91. PubMed ID: 17047172
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bedtime administration of lansoprazole does not modify its greater efficacy vs ranitidine in the acute and long-term treatment of duodenal ulcer. Results from a multicentre, randomised, double blind clinical trial.
    Russo A; Dattilo M
    Ital J Gastroenterol Hepatol; 1997 Aug; 29(4):312-9. PubMed ID: 9476183
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Double blind multicentre comparison of omeprazole 20 mg once daily versus ranitidine 150 mg twice daily in the treatment of cimetidine or ranitidine resistant duodenal ulcers.
    Delchier JC; Isal JP; Eriksson S; Soule JC
    Gut; 1989 Sep; 30(9):1173-8. PubMed ID: 2680793
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Continuous infusion of pantoprazole versus ranitidine for prevention of ulcer rebleeding: a U.S. multicenter randomized, double-blind study.
    Jensen DM; Pace SC; Soffer E; Comer GM;
    Am J Gastroenterol; 2006 Sep; 101(9):1991-9; quiz 2170. PubMed ID: 16968504
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical evaluation of the effect of omeprazole, cimetidine, famotidine and ranitidine on histamine induced cutaneous wheal and flare response.
    Saha N; Sachdev A; Bhasin DK; Sankaranahyanan A; Khosla PP; Singh K; Sharma PL
    Int J Clin Pharmacol Ther Toxicol; 1993 Jul; 31(7):322-5. PubMed ID: 8103763
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Energy absorption as a measure of intestinal failure in the short bowel syndrome.
    Rodrigues CA; Lennard-Jones JE; Thompson DG; Farthing MJ
    Gut; 1989 Feb; 30(2):176-83. PubMed ID: 2495238
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Teduglutide (ALX-0600), a dipeptidyl peptidase IV resistant glucagon-like peptide 2 analogue, improves intestinal function in short bowel syndrome patients.
    Jeppesen PB; Sanguinetti EL; Buchman A; Howard L; Scolapio JS; Ziegler TR; Gregory J; Tappenden KA; Holst J; Mortensen PB
    Gut; 2005 Sep; 54(9):1224-31. PubMed ID: 16099790
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Intravenous omeprazole versus ranitidine in the treatment of hemorrhagic duodenal ulcer: a prospective randomized study].
    Cardi M; Muttillo IA; Amadori L; Barillari P; Sammartino P; Arnone F; Signorelli C; Bolognese A
    Ann Chir; 1997; 51(2):136-9. PubMed ID: 9297869
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quality of life during acute and intermittent treatment of gastro-oesophageal reflux disease with omeprazole compared with ranitidine. Results from a multicentre clinical trial. The European Study Group.
    Wiklund I; Bardhan KD; Müller-Lissner S; Bigard MA; Bianchi Porro G; Ponce J; Hosie J; Scott M; Weir D; Fulton C; Gillon K; Peacock R
    Ital J Gastroenterol Hepatol; 1998 Feb; 30(1):19-27. PubMed ID: 9615259
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The impact of primary antibiotic resistance on the efficacy of ranitidine bismuth citrate- vs. omeprazole-based one-week triple therapies in H. pylori eradication--a randomised controlled trial.
    Bago J; Halle ZB; Strinić D; Kućisec N; Jandrić D; Bevanda M; Tomić M; Bilić A
    Wien Klin Wochenschr; 2002 Jun; 114(12):448-53. PubMed ID: 12422579
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Omeprazole or ranitidine for intermittent treatment of GERD?
    Salzberg SA; Newton WP
    J Fam Pract; 1999 May; 48(5):332-3. PubMed ID: 10334603
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.